An Open-label, Single-arm, Two-period, Fixed Sequential-dose Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of SP 102 (Dexamethasone Sodium Phosphate Injectable Gel) Administered by Epidural Injection Compared with Dexamethasone Sodium Phosphate Injection, Administered by Intravenous Injection in Subjects with Lumbosacral Radiculopathy
Latest Information Update: 18 Jul 2022
At a glance
- Drugs Dexamethasone (Primary) ; Dexamethasone
- Indications Sciatica
- Focus Pharmacokinetics
- Sponsors Semnur Pharmaceuticals
Most Recent Events
- 12 Jul 2022 Results published in the International Journal of Clinical Pharmacology and Therapeutics
- 27 Mar 2019 New trial record